Exicure (XCUR) Assets Average (2017 - 2026)
Exicure's (XCUR) quarterly Assets Average came in at $13.4 million in Q1 2026, down 25.02% YoY from $17.9 million in Q1 2025, and down 8.57% on a QoQ basis from $14.7 million in Q4 2025.
Exicure (XCUR) Assets Average (2017 - 2026) Analysis & Trends
Exicure (XCUR) has 10 years of Assets Average data on file, last reported at $13.4 million in Q1 2026.
- Quarterly Assets Average fell 25.02% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.4 million (down 25.02% YoY) and the FY2025 annual result came in at $14.5 million, up 9.24% from the prior year.
- Assets Average declined to $13.4 million in Q1 2026, from $14.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $53.4 million in Q1 2022 to a low of $10.7 million in Q3 2024.
- A 5-year average of $20.7 million and a median of $17.0 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average plunged 63.39% — and 2025, when it jumped 84.2%.
- Tracing XCUR's Assets Average over 5 years: stood at $26.1 million in 2022, then tumbled by 53.07% to $12.3 million in 2023, then advanced by 4.72% to $12.8 million in 2024, then rose by 14.1% to $14.7 million in 2025, then slipped by 8.57% to $13.4 million in 2026.
- The last three Assets Average figures came in at $13.4 million (Q1 2026), $14.7 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Exicure | 8.41 Mn | 8.41 Mn | - | 12.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.40 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 19.71 Mn |
| Mar 31, 2025 | 17.87 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | 10.66 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 11.15 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 15.25 Mn |
| Jun 30, 2023 | 20.75 Mn |
| Mar 31, 2023 | 23.64 Mn |
| Dec 31, 2022 | 26.14 Mn |
| Sep 30, 2022 | 32.95 Mn |
| Jun 30, 2022 | 39.43 Mn |
| Mar 31, 2022 | 53.38 Mn |
| Dec 31, 2021 | 71.38 Mn |
| Sep 30, 2021 | 76.18 Mn |
| Jun 30, 2021 | 81.21 Mn |